Sanofi - Aventis Groupe: Press Release: Phase 2 data publish

Sanofi - Aventis Groupe: Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS

Sanofi - Aventis Groupe: Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Paris , France General , France , Stefan Klotter , Eva Schaefer Jansen , Timothy Gilbert , Felix Lauscher , Sandrine Guendoul , Tarik Elgoutni , Nathalie Pham , Patrick Vermersch , Sally Bain , Corentine Driancourt , Consortium Of Multiple Sclerosis Centers , Euronext , Immunext Inc , Nasdaq , University Of Lille , New England Journal , Multiple Sclerosis Centers , Multiple Sclerosis Impact Scale , Multiple Sclerosis , Systemic Lupus Erythematosus , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , Lassen Sie ,